BACKGROUND: Over the past decade, minimally invasive (MI) mitral valve surgery has grown in popularity. The purpose of this study was to compare both short- and long-term outcomes of mitral valve repair and replacement performed through a MI versus traditional sternotomy (ST) incision using a propensity analysis approach to account for differences in baseline risk. METHODS: From January 2000 to December 2008, a total of 1,121 isolated mitral valve operations were performed at our institution (548 ST, 573 MI). Data were retrospectively collected on all patients, and a logistic regression model was created to predict selection to a MI versus ST approach. Propensity scores were then generated based on the regression model and matched pairs created using 1:1 nearest neighbor matching. There were 382 matched pairs in the analysis for a total sample size of 764, or 68.2% of the original cohort. Major outcomes of interest included cardiopulmonary bypass time, cross-clamp time, hospital length of stay, major in-hospital complications, and both short- and long-term survival. RESULTS: Cardiopulmonary bypass time was 117.1 ± 2.0 minutes in the ST group and 139.7 ± 2.6 minutes in the MI group (p < 0.0001), and cross-clamp time was 79.6 ± 1.5 minutes in the ST group and 83.7 ± 1.9 in the MI group (p = 0.106). The average hospital length of stay was 9.81 ± 0.61 days among ST patients and 7.76 ± 0.37 days among MI patients (p = 0.0043). There was no significant difference in the frequency of major in-hospital complications between groups. The mean duration of survival follow-up was 4.2 ± 2.4 years. There was no significant difference in mortality at 30 days (p = 0.622) or 1 year (p = 0.599). In addition, there was no significant difference in long-term survival between groups (p = 0.569). CONCLUSIONS: Although minimally invasive mitral valve surgery required a slightly longer cardiopulmonary bypass time, there was no difference in cross-clamp time, morbidity, or mortality, and hospital length of stay was significantly shorter when compared with matched sternotomy control patients.
BACKGROUND: Over the past decade, minimally invasive (MI) mitral valve surgery has grown in popularity. The purpose of this study was to compare both short- and long-term outcomes of mitral valve repair and replacement performed through a MI versus traditional sternotomy (ST) incision using a propensity analysis approach to account for differences in baseline risk. METHODS: From January 2000 to December 2008, a total of 1,121 isolated mitral valve operations were performed at our institution (548 ST, 573 MI). Data were retrospectively collected on all patients, and a logistic regression model was created to predict selection to a MI versus ST approach. Propensity scores were then generated based on the regression model and matched pairs created using 1:1 nearest neighbor matching. There were 382 matched pairs in the analysis for a total sample size of 764, or 68.2% of the original cohort. Major outcomes of interest included cardiopulmonary bypass time, cross-clamp time, hospital length of stay, major in-hospital complications, and both short- and long-term survival. RESULTS: Cardiopulmonary bypass time was 117.1 ± 2.0 minutes in the ST group and 139.7 ± 2.6 minutes in the MI group (p < 0.0001), and cross-clamp time was 79.6 ± 1.5 minutes in the ST group and 83.7 ± 1.9 in the MI group (p = 0.106). The average hospital length of stay was 9.81 ± 0.61 days among ST patients and 7.76 ± 0.37 days among MI patients (p = 0.0043). There was no significant difference in the frequency of major in-hospital complications between groups. The mean duration of survival follow-up was 4.2 ± 2.4 years. There was no significant difference in mortality at 30 days (p = 0.622) or 1 year (p = 0.599). In addition, there was no significant difference in long-term survival between groups (p = 0.569). CONCLUSIONS: Although minimally invasive mitral valve surgery required a slightly longer cardiopulmonary bypass time, there was no difference in cross-clamp time, morbidity, or mortality, and hospital length of stay was significantly shorter when compared with matched sternotomy control patients.
Authors: H Y Karagoz; K Bayazit; B Battaloglu; M Kurtoglu; G Ozerdem; B Bakkaloglu; B Sönmez Journal: Ann Thorac Surg Date: 1999-05 Impact factor: 4.330
Authors: Tayfun Aybek; Selami Dogan; Petar S Risteski; Andreas Zierer; Thomas Wittlinger; Gerhard Wimmer-Greinecker; Anton Moritz Journal: Ann Thorac Surg Date: 2006-05 Impact factor: 4.330
Authors: Renato A Apolito; Mark A Greenberg; Mark A Menegus; April M Lowe; Lynn A Sleeper; Mark H Goldberger; Joshua Remick; Martha J Radford; Judith S Hochman Journal: Am Heart J Date: 2007-12-19 Impact factor: 4.749
Authors: Raymond J Gibbons; Timothy J Gardner; Jeffrey L Anderson; Larry B Goldstein; Neil Meltzer; William S Weintraub; Clyde W Yancy Journal: Circulation Date: 2009-05-11 Impact factor: 29.690
Authors: Aubrey C Galloway; Charles F Schwartz; Greg H Ribakove; Gregory A Crooke; George Gogoladze; Patricia Ursomanno; Margaret Mirabella; Alfred T Culliford; Eugene A Grossi Journal: Ann Thorac Surg Date: 2009-10 Impact factor: 4.330
Authors: E A Grossi; A C Galloway; G H Ribakove; P K Zakow; C C Derivaux; F G Baumann; D Schwesinger; S B Colvin Journal: Ann Thorac Surg Date: 2001-03 Impact factor: 4.330
Authors: Pasquale Totaro; Simone Carlini; Matteo Pozzi; Francesco Pagani; Giuseppe Zattera; Andrea Maria D'Armini; Mario Vigano Journal: Ann Thorac Surg Date: 2009-08 Impact factor: 4.330
Authors: James P Greelish; Lawrence H Cohn; Marzia Leacche; Michael Mitchell; Alexandros Karavas; John Fox; John G Byrne; Sary F Aranki; Gregory S Couper Journal: J Thorac Cardiovasc Surg Date: 2003-08 Impact factor: 5.209
Authors: Alexander Iribarne; Anna Karpenko; Mark J Russo; Faisal H Cheema; Faisal Cheema; Tianna Umann; Mehmet C Oz; Craig R Smith; Michael Argenziano Journal: World J Surg Date: 2010-04 Impact factor: 3.352
Authors: Alexander Iribarne; Rachel Easterwood; Mark J Russo; Y Claire Wang; Jonathan Yang; Kimberly N Hong; Craig R Smith; Michael Argenziano Journal: J Thorac Cardiovasc Surg Date: 2011-06-14 Impact factor: 5.209
Authors: Andrew B Goldstone; Pavan Atluri; Wilson Y Szeto; Alen Trubelja; Jessica L Howard; John W MacArthur; Craig Newcomb; Joseph P Donnelly; Dale M Kobrin; Mary A Sheridan; Christiana Powers; Robert C Gorman; Joseph H Gorman; Alberto Pochettino; Joseph E Bavaria; Michael A Acker; W Clark Hargrove; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2013-03 Impact factor: 5.209